drugs, food, and programs is worth $12 billion a year but that number could increase another $2.4 billion by tapping into some areas of weight loss niches (LaRosa, 2012). With a huge market opportunity and the obesity numbers rising, there is a growing need for treatments to counter the epidemic. Helapharm, a small startup company, is in the process of developing a novel peptide from the saliva of a Gila Monster to treat obesity. Although the peptide has shown anti-obesity traits in its early…
Words 3290 - Pages 14